Literature DB >> 7798214

Molecular characterization of native and recombinant apolipoprotein A-IMilano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I.

L Calabresi1, G Vecchio, R Longhi, E Gianazza, G Palm, H Wadensten, A Hammarström, A Olsson, A Karlström, T Sejlitz.   

Abstract

The disulfide-linked dimer of apolipoprotein A-IMilano (A-IM/A-IM), a natural Arg173-->Cys variant of apoA-I, was purified from carriers' plasma and produced in Escherichia coli. The recombinant A-IM/A-IM is identical to native A-IM/A-IM, by mass spectrometry, SDS-polyacrylamide gel electrophoresis, and isoelectric focusing. Lipid-free A-IM/A-IM undergoes concentration-dependent self-association similar to apoA-I, but at all concentrations apoA-I is more self-associated than A-IM/A-IM. Far-ultraviolet CD spectra of A-IM/A-IM reveal a highly alpha-helical structure predicted to be approximately 65% in the lipid-free and approximately 78% in the lipid-associated states, versus 43 and 73% for apoA-I. A significant loss of alpha-helix occurs below pH 3.5 and above pH 10 in both apoA-I and A-IM/A-IM; A-IM/A-IM constantly shows a higher alpha-helical content than apoA-I over the entire pH range (1.7-12.8), suggesting that hydrophobic forces stabilize the interaction between the two A-IM chains. Indeed, and differently from apoA-I, the alpha-helical content of A-IM/A-IM is minimally affected by solvent ionic strength. The aromatic side chains in both lipid-free and lipid-bound A-IM/A-IM are immobilized in a more asymmetric and hydrophobic environment than in lipid-free apoA-I, the conformation of A-IM/A-IM being instead similar to that achieved by apoA-I following interaction with lipids. The present findings prove that rA-IM/A-IM is structurally identical to the native protein; the conformation of A-IM/A-IM is remarkably different from that of apoA-I, thus possibly explaining some of the peculiar functional properties of the apoA-IMilano dimer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.

Authors:  Amar A Sethi; John A Stonik; Fairwell Thomas; Steve J Demosky; Marcelo Amar; Edward Neufeld; H Bryan Brewer; W Sean Davidson; Wilissa D'Souza; Dmitri Sviridov; Alan T Remaley
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

2.  Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Laura Calabresi; Michael P Samuel; Michael J Thomas
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

3.  A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis.

Authors:  Alessandro Guerini Rocco; Luca Mollica; Elisabetta Gianazza; Laura Calabresi; Guido Franceschini; Cesare R Sirtori; Ivano Eberini
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

4.  Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins.

Authors:  Elisabetta Gianazza; Ivano Eberini; Cesare R Sirtori; Guido Franceschini; Laura Calabresi
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

Authors:  Herman J Kempen; Monica Gomaraschi; S Eralp Bellibas; Stephanie Plassmann; Brad Zerler; Heidi L Collins; Steven J Adelman; Laura Calabresi; Peter L J Wijngaard
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

Review 6.  Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases.

Authors:  Laura Calabresi; Cesare R Sirtori; Rodolfo Paoletti; Guido Franceschini
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

7.  Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I.

Authors:  Eric T Alexander; Masafumi Tanaka; Momoe Kono; Hiroyuki Saito; Daniel J Rader; Michael C Phillips
Journal:  J Lipid Res       Date:  2009-03-24       Impact factor: 5.922

Review 8.  HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

Authors:  Alan T Remaley; Marcelo Amar; Dmitri Sviridov
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-10

9.  Effects of disulfide bond formation and protein helicity on the aggregation of activating transcription factor 5.

Authors:  Natalie A Ciaccio; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

Review 10.  Structural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-I.

Authors:  Olga Gursky; Martin K Jones; Xiaohu Mei; Jere P Segrest; David Atkinson
Journal:  J Lipid Res       Date:  2013-09-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.